The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt

Infection, Genetics and Evolution

Volumn 12, Issue 6, 2012, Pages 1189-1194

  Farawela, Hala ^a   Khorshied, Mervat ^a   Shaheen, Iman ^a   Gouda, Heba ^a   Nasef, Aya ^a   Abulata, Nelly ^a   Mahmoud, Hebat Allah ^b   Zawam, Hamdy M ^a   Mousa, Somaia M ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b MINISTRY OF HEALTH   (Egypt)

Author keywords

Antioxidant enzymes; B NHL; Genetic polymorphism; HCV; NHL risk; Oxidative stress genes

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CANCER RISK; CAT GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EGYPT; ETHNIC GROUP; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GPX1 GENE; HEPATITIS C; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MPO GENE; NOS2 GENE; ONCOGENE; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; SOD2 GENE;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; MUTATION; OXIDATIVE STRESS; OXIDOREDUCTASES; POLYMORPHISM, GENETIC; RISK;

HEPATITIS C VIRUS;

EID: 84861946118     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.04.007     Document Type: Article

References (48)

1. Abdel-Fattah M.M., Yassine O.G. Non-Hodgkin's lymphomas in Alexandria, Egypt; incidence rates and trend study (1995-2004). Eur. J. Cancer Prev. 2007, 16(5):479-485.
2. Ahn, J., Gammon, M.D., Santella, R.M., Gaudet, M.M., Britton, J.A., Teitelbaum, S.L., Terry, M.B., Nowell, S., Davis, W., Garza, C., Neugut, A.I., Ambrosone, C.B., 2005. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am. J. Epidemiol. 162(10), 943-952.
3. Armitage J.O. Staging non-Hodgkin lymphoma. CA Cancer J. Clin. 2005, 55:368-376.
4. Atik E., Ergin M., Erdoĝan S., Tuncer I. Inducible nitric oxide synthase and apoptosis in human B cell lymphomas. Mol. Cell. Biochem. 2006, 290(1-2):205-209.
5. Betteridge D.J. What is oxidative stress?. Metabolism 2000, 49(Suppl. 1):3-8.
6. Cascorbi, I., Henning, S., Brockmöller, J., Gephart, J., Meisel, C., Müller, J.M., Loddenkemper, R., Roots, I., 2000. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene. Cancer Res. 60(3), 644-649.
7. Chu H., Wang M., Wang M., Gu D., Wu D., Zhang Z., Tang J., Zhang Z. The MPO-463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies. Mutagenesis 2010, 25(4):389-395.
8. Cowgill K.D., Loffredo C.A., Eissa S.A., Mokhtar N., Abdel-Hamid M., Fahmy A., Strickland G.T. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int. J. Epidemiol. 2004, 33(5):1034-1039.
9. Cullen J.J., Mitros F.A., Oberley L.W. Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas 2003, 26(1):23-27.
10. Dal Maso L., Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol. Biomark. Prev. 2006, 15(11):2078-2085.
11. de Sanjose S., Benavente Y., Vajdic C.M., Engels E.A., Morton L.M., Bracci P.M., Spinelli J.J., Zheng T., Zhang Y., Franceschi S., Talamini R., Holly E.A., Grulich A.E., Cerhan J.R., Hartge P., Cozen W., Boffetta P., Brennan P., Maynadié M., Cocco P., Bosch R., Foretova L., Staines A., Becker N., Nieters A. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin. Gastroenterol. Hepatol. 2008, 6(4):451-458.
12. El-Zanaty, F., Way, A., 2009. Egypt Demographic and Health Survey 2008. Egyptian: Ministry of Health (El-Zanaty and Associates and Macro International, Cairo), pp. 252.
13. Ezzikouri, S., El Feydi, A.E., Chafik, A., Afifi, R., El Kihal, L., Benazzouz, M., Hassar, M., Pineau, P., Benjelloun, S., 2008. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients. Mutat. Res. 649(1-2), 1-6.
14. Ezzikouri S., El Feydi A.E., Afifi R., Benazzouz M., Hassar M., Pineau P., Benjelloun S. Polymorphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a Moroccan population. Free Radic. Res. 2010, 44(2):208-216.
15. Flekac M., Skrha J., Hilgertova J., Lacinova Z., Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med. Genet. 2008, 9(3).
16. Forsberg L., de Faire U., Morgenstern R. Low yield of polymorphisms from EST Blast searching: analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPx1. Hum. Mutat. 1999, 13:294-300.
17. Förstermann, U., Gath, I., Schwarz, P., Closs, E.I., Kleinert, H., 1995. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem. Pharmacol. 50(9), 1321-1332 (Review).
18. Gallo, O., Masini, E., Morbidelli, L., Franchi, A., Fini-Storchi, I., Vergari, W.A., Ziche, M., 1998. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer Inst. 90(8), 587-596.
19. Goldman L., Ezzat S., Mokhtar N., Abdel-Hamid A., Fowler N., Gouda I., Eissa S.A., Abdel-Hamid M., Loffredo C.A. Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 2009, 20(6):981-987.
20. Hamanishi T., Furuta H., Kato H., Doi A., Tamai M., Shimomura H., Sakagashira S., Nishi M., Sasaki H., Sanke T., Nanjo K. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes 2004, 53(9):2455-2460.
21. He C., Qureshi A.A., Han J. Polymorphisms in genes involved in oxidative stress and their interactions with lifestyle factors on skin cancer risk. J. Dermatol. Sci. 2010, 60(1):54-56.
22. Hu, D.E., Dyke, S.O., Moore, A.M., Thomsen, L.L., Brindle, K.M., 2004. Tumor cell-derived nitric oxide is involved in the immune-rejection of an immunogenic murine lymphoma. Cancer Res. 64 (1), 152-161.
23. Hung R.J., Boffetta P., Brennan P., Malaveille C., Gelatti U., Placidi D., Carta A., Hautefeuille A., Porru S. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 2004, 25(6):973-978.
24. Krajinovic, M., Sinnett, H., Richer, C., Labuda, D., Sinnett, D., 2002. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int. J. Cancer 97(2), 230-236.
25. Lan Q., Zheng T., Shen M., Zhang Y., Wang S.S., Zahm S.H., Holford T.R., Leaderer B., Boyle P., Chanock S. Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum. Genet. 2007, 121(2):161-168.
26. Lightfoot, T.J., Skibola, C.F., Smith, A.G., Forrest, M.S., Adamson, P.J., Morgan, G.J., Bracci, P.M., Roman, E., Smith, M.T., Holly, E.A., 2006. Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica 91(9), 1222-1227.
27. Liu, G., Zhou, W., Wang, L.I., Park, S., Miller, D.P., Xu, L.L., Wain, J.C., Lynch, T.J., Su, L., Christiani, D.C., 2004. MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma. Cancer Lett. 214(1), 69-79.
28. London, S.J., Lehman, T.A., Taylor, J.A., 1997. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 57(22), 5001-5003.
29. Mannick, J.B., Asano, K., Izumi, K., Kieff, E., Stamler, J.S., 1994. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79(7), 1137-1146.
30. McElnea E.M., Quill B., Docherty N.G., Irnaten M., Siah W.F., Clark A.F., O'Brien C.J., Wallace D.M. Oxidative stress, mitochondrial dysfunction and calcium overload inhuman lamina cribrosa cells from glaucoma donors. Mol. Vis. 2011, 17:1182-1191.
31. Mendes R.V., Martins A.R., de Nucci G., Murad F., Soares F.A. Expression of nitric oxide synthase isoforms and nitrotyrosine immunoreactivity by B-cell non-Hodgkin's lymphomas and multiple myeloma. Histopathology 2001, 39(2):172-178.
32. Nemoto M., Nishimura R., Sasaki T., Hiki Y., Miyashita Y., Nishioka M., Fujimoto K., Sakuma T., Ohashi T., Fukuda K., Eto Y., Tajima N. Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Cardiovasc. Diabetol. 2007, 7(6):23.
33. Olson S.H., Carlson M.D., Ostrer H., Harlap S., Stone A., Winters M., Ambrosone C.B. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol. Oncol. 2004, 93(3):615-620.
34. Park H.H., Ha E., Uhm Y.K., Jin S.Y., Kim Y.J., Chung J.H., Lee M.H. Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population. Exp. Dermatol. 2006, 15(5):377-380.
35. Rajp A., Adu D., Savage C.O. Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis. Clin. Exp. Immunol. 2007, 149(2):251-256.
36. Ratnasinghe, D., Tangrea, J.A., Andersen, M.R., Barrett, M.J., Virtamo, J., Taylor, P.R., Albanes, D., 2000. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 60(22), 6381-6383.
37. Ravn-Haren G., Olsen A., Tjønneland A., Dragsted L.O., Nexø B.A., Wallin H., Overvad K., Raaschou-Nielsen O., Vogel U. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 2006, 27(4):820-825.
38. Shen, J., Wang, R.T., Wang, L.W., Xu, Y.C., Wang, X.R., 2004. A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer. World J. Gastroenterol. 10(22), 3278-3283.
39. Skibola C.F., Curry J.D., Nieters A. Genetic susceptibility to lymphoma. Haematologica 2007, 92(07):960-969.
40. Smedby K.E., Lindgren C.M., Hjalgrim H., Humphreys K., Schöllkopf C., Chang E.T., Roos G., Ryder L.P., Falk K.I., Palmgren J., Kere J., Melbye M., Glimelius B., Adami H.O. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol. Biomark. Prev. 2006, 15(2):258-265.
41. Stuehr, D.J., 1999. Mammalian nitric oxide synthases. Biochim. Biophys. Acta 1411(2-3), 217-230.
42. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., Vardiman, J.W. (Eds.), 2008. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
43. Tome, M.E., Johnson, D.B., Rimsza, L.M., Roberts, R.A., Grogan, T.M., Miller, T.P., Oberley, L.W., Briehl, M.M., 2005. A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. Blood 106(10), 3594-3601.
44. van de Sande, W.W., Fahal, A., Verbrugh, H., van Belkum, A., 2007. Polymorphisms in genes involved in innate immunity predispose toward mycetoma susceptibility. J. Immunol. 179(5), 3065-3074.
45. Varma S., Menon M.C., Garg A., Malhotra P., Sharma A., Chawla Y.K., Dhiman R.K. Hepatitis C virus infection among patients with non-Hodgkin's lymphoma in northern India. Hepatol. Int. 2011, 5(2):688-692.
46. Wang, L.I., Miller, D.P., Sai, Y., Liu, G., Su, L., Wain, J.C., Lynch, T.J., Christiani, D.C., 2001. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J. Natl. Cancer Inst. 93(23), 1818-1821.
47. Wang S.S., Davis S., Cerhan J.R., Hartge P., Severson R.K., Cozen W., Lan Q., Welch R., Chanock S.J., Rothman N. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 2006, 27(9):1828-1834.
48. Wang, S.S., Slager, S.L., Brennan, P., Holly, E.A., De Sanjose, S., Bernstein, L., Boffetta, P., Cerhan, J.R., Maynadie, M., Spinelli, J.J., Chiu, B.C., Cocco, P.L., Mensah, F., Zhang, Y., Nieters, A., Dal Maso, L., Bracci, P.M., Costantini, A.S., Vineis, P., Severson, R.K., Roman, E., Cozen, W., Weisenburger, D., Davis, S., Franceschi, S., La Vecchia, C., Foretova, L., Becker, N., Staines, A., Vornanen, M., Zheng, T., Hartge, P., 2007. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 109(8), 3479-3488.